Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Inseego
INSG
$114M
| $514K | ﹤0.01% |
61,056
+1,305
| +2% | +$19.6K |
|
3002
Dragonfly Energy
DFLI
$15M
| $514K | ﹤0.01% |
+480
| New | +$457K |
|
3003
Unity Bancorp
UNTY
$591M
| $504K | ﹤0.01% |
18,432
+573
| +3% | +$15.7K |
|
3004
Aura Biosciences
AURA
$725M
| $502K | ﹤0.01% |
47,807
+804
| +2% | +$10.2K |
|
|
NETI
3005
DELISTED
Eneti Inc.
NETI
| $499K | ﹤0.01% |
49,627
-2,626
| -5% | -$23.3K |
|
3006
Distribution Solutions Group
DSGR
$1.6B
| $498K | ﹤0.01% |
27,044
+866
| +3% | +$14.5K |
|
3007
IBEX
IBEX
$473M
| $498K | ﹤0.01% |
20,038
+7,271
| +57% | +$164K |
|
3008
SkyWater Technology
SKYT
| $498K | ﹤0.01% |
69,976
+8,726
| +14% | +$73.8K |
|
|
HLGN
3009
DELISTED
Heliogen, Inc.
HLGN
| $497K | ﹤0.01% |
20,329
+712
| +4% | +$32.1K |
|
3010
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
| $491K | ﹤0.01% |
23,149
-1,574
| -6% | -$33.8K |
|
3011
System1
SST
$14.3M
| $490K | ﹤0.01% |
10,440
+139
| +1% | +$7.14K |
|
3012
PepGen
PEPG
$122M
| $484K | ﹤0.01% |
36,236
+12,542
| +53% | +$162K |
|
3013
Blue Bird Corp
BLBD
$2.35B
| $480K | ﹤0.01% |
44,835
+1,459
| +3% | +$14.7K |
|
3014
AXT Inc
AXTI
$3.95B
| $477K | ﹤0.01% |
108,834
+3,220
| +3% | +$15.7K |
|
3015
Kodak
KODK
$822M
| $475K | ﹤0.01% |
155,796
+3,249
| +2% | +$14.3K |
|
|
ALPN
3016
DELISTED
Alpine Immune Sciences Inc
ALPN
| $474K | ﹤0.01% |
64,496
+24,673
| +62% | +$158K |
|
|
KRON
3017
DELISTED
Kronos Bio
KRON
| $469K | ﹤0.01% |
289,515
-27,262
| -9% | -$62.7K |
|
3018
Brookfield Renewable
BEPC
$6.08B
| $468K | ﹤0.01% |
16,991
+502
| +3% | +$15.5K |
|
3019
Silvercrest Asset Management
SAMG
$79M
| $468K | ﹤0.01% |
24,921
-104
| -0.4% | -$1.87K |
|
3020
Safe Bulkers
SB
$795M
| $467K | ﹤0.01% |
160,408
-380
| -0.2% | -$1.05K |
|
3021
Global Water Resources
GWRS
$206M
| $466K | ﹤0.01% |
35,122
| – | – |
|
|
ICVX
3022
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $466K | ﹤0.01% |
58,733
+9,894
| +20% | +$42.5K |
|
3023
Xeris Biopharma Holdings
XERS
$1.39B
| $463K | ﹤0.01% |
348,237
+10,410
| +3% | +$14.7K |
|
3024
HSBC
HSBC
$365B
| $462K | ﹤0.01% |
+14,835
| New | +$421K |
|
3025
Lifecore Biomedical
LFCR
$166M
| $452K | ﹤0.01% |
69,828
+1,836
| +3% | +$15.1K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.